Yunnan Botanee Bio-Technology Group Co.LTD (300957.SZ)
CNY 45.43
(-2.26%)
CNY 45.43
(-2.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 669.18 Million | 769.44 Million | 1.15 Billion | 431.02 Million | 514.92 Million | 102.19 Million |
| Net Income | 756.79 Million | 1.05 Billion | 864.06 Million | 543.75 Million | 413.06 Million | 262.92 Million |
| Depreciation & Amortization | 174.63 Million | 92.82 Million | 58.52 Million | 13.74 Million | 11.76 Million | 7.06 Million |
| Deferred income taxes | -89.33 Million | -29.28 Million | -1.86 Million | -2.94 Million | -3.44 Million | -1.15 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -186.08 Million | -346.65 Million | 223.99 Million | -150.56 Million | 67.58 Million | -182.5 Million |
| Other non-cash items | 548.52 Million | -27.14 Million | 6.13 Million | 24.09 Million | 22.51 Million | 14.72 Million |
| Investing Cash Flow | -586.8 Million | -18.48 Million | -2.55 Billion | -86.32 Million | -60.85 Million | -28.72 Million |
| Investments in PPE | -274.27 Million | -353.42 Million | -270.68 Million | -89.45 Million | -61.01 Million | -31.55 Million |
| Acquisitions | -500.61 Million | -7.47 Million | -6.5 Million | 89.45 Million | 61.01 Million | 2.83 Million |
| Investment purchases | -4.9 Billion | -6.8 Billion | -8.62 Billion | -760 Million | -60 Million | - |
| Sales/Maturities of investments | 5.09 Billion | 7.14 Billion | 6.34 Billion | 763.13 Million | 60.14 Million | - |
| Other Investing Activities | 249.71 Million | 10.8 Thousand | 226.37 Thousand | -89.45 Million | -61.01 Million | 847.95 |
| Financing Cash Flow | -448.47 Million | -319.66 Million | 2.66 Billion | -121.04 Million | -177.97 Million | -85.24 Million |
| Debt repayment | -81.24 Million | -64.71 Million | -42.89 Million | -14.93 Million | -14.93 Million | -42.98 Million |
| Dividends payments | -339.13 Million | -55.46 Million | -190.62 Million | -100.8 Million | -100.8 Million | -37.36 Million |
| Common Stock Repurchased | -109.83 Million | - | -2.86 Billion | - | -14.78 Million | - |
| Common Stock Issuance | - | - | 2.9 Billion | -1.8 Million | -148 Thousand | - |
| Other Financing Activities | -343.43 Million | -784 Thousand | 2.85 Billion | -18.89 Million | 42.69 Million | -4.9 Million |
| Accounts receivables | 162.53 Million | -222.64 Million | -45.09 Million | -186.54 Million | -64.84 Million | -69.25 Million |
| Accounts payables | - | 119.41 Million | 490.73 Million | 90.61 Million | 80.88 Million | 34.3 Million |
| Inventory | -348.62 Million | -214.14 Million | -221.43 Million | -51.69 Million | 55 Million | -146.4 Million |
| Other working capital | -89.33 Million | -29.28 Million | -210.91 Thousand | -2.94 Million | -3.44 Million | -36.09 Million |
| Cash at beginning of period | 2.51 Billion | 2 Billion | 750.89 Million | 527.23 Million | 251.14 Million | 262.92 Million |
| Cash at end of period | 2.09 Billion | 2.44 Billion | 2 Billion | 750.89 Million | 527.23 Million | 251.14 Million |
| Capital Expenditure | -274.27 Million | -353.42 Million | -270.68 Million | -89.45 Million | -61.01 Million | -31.55 Million |
| Effect of forex changes on cash | -724.66 Thousand | 25.73 Thousand | -4205.54 | -0.24 | -13.75 | -1036.55 |
| Net cash flow / Change in cash | -422.83 Million | 431.32 Million | 1.25 Billion | 223.65 Million | 276.08 Million | -11.77 Million |
| Free Cash Flow | 394.9 Million | 416.02 Million | 882.03 Million | 341.57 Million | 453.91 Million | 70.63 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -68.99 Million | 306.92 Million | 176.84 Million | 177.6 Million | 756.79 Million | 129.17 Million |
| Depreciation & Amortization | - | 56.74 Million | 56.74 Million | 48.75 Million | 174.63 Million | -54.71 Million |
| Deferred income taxes | - | - | - | - | -89.33 Million | -14 Million |
| Stock-based compensation | - | - | - | - | - | -556.82 Thousand |
| Change in working capital | - | 14.14 Million | - | - | -186.08 Million | 49.53 Million |
| Other non-cash items | -53.75 Million | 67.52 Million | -323.25 Million | 365.89 Million | 548.52 Million | -269.94 Million |
| Investing Cash Flow | -280.42 Million | -329.85 Million | -442.43 Million | -4.31 Million | -586.8 Million | 193.34 Million |
| Investments in PPE | -80.47 Million | -104.96 Million | -70.93 Million | -119.09 Million | -274.27 Million | -51.87 Million |
| Acquisitions | 36.59 Thousand | 1.19 Million | - | -507.13 Million | -500.61 Million | 7.5 Million |
| Investment purchases | -1.41 Billion | -1.36 Billion | -1.04 Billion | -635.08 Million | -4.9 Billion | -1.41 Billion |
| Sales/Maturities of investments | 1.21 Billion | 1.14 Billion | 670 Million | 1.25 Billion | 5.09 Billion | 1.66 Billion |
| Other Investing Activities | 36.55 Thousand | -206.11 Million | -360.19 Million | 630.54 Million | 249.71 Million | -7.5 Million |
| Financing Cash Flow | -54.99 Million | 218.17 Million | -156.65 Million | -48.94 Million | -448.47 Million | -11.03 Million |
| Debt repayment | -24.84 Million | -522.04 Million | -38.42 Million | - | -81.24 Million | - |
| Dividends payments | -4.62 Million | -253.14 Million | -1.27 Million | -259.87 Thousand | -339.13 Million | - |
| Common Stock Repurchased | 119.85 Million | -119.85 Million | - | -109.83 Million | -109.83 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -25.52 Million | -137.7 Million | -118.23 Million | 56.08 Million | -343.43 Million | -11.03 Million |
| Accounts receivables | - | -124.4 Million | - | - | 162.53 Million | 57.83 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | 138.54 Million | - | - | -348.62 Million | -8.29 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.53 Billion | 1.34 Billion | 2.09 Billion | 1.64 Billion | 2.51 Billion | 1.61 Billion |
| Cash at end of period | 1.06 Billion | 1.62 Billion | 1.34 Billion | 2.09 Billion | 2.09 Billion | 1.63 Billion |
| Capital Expenditure | -80.47 Million | -104.96 Million | -70.93 Million | -119.09 Million | -274.27 Million | -51.87 Million |
| Effect of forex changes on cash | 2.7 Million | -496.46 Thousand | -942.9 Thousand | -729.69 Thousand | -724.66 Thousand | -856.63 |
| Net cash flow / Change in cash | -467.76 Million | 286.34 Million | -748.01 Million | 450.37 Million | -422.83 Million | 21.79 Million |
| Free Cash Flow | -203.23 Million | 212.73 Million | -217.34 Million | 375.64 Million | 394.9 Million | -212.38 Million |
NMRK
DSFIR
8611
ENI
SUBROS
0IH3